Abstract: A method comprising detecting an activation of an intelligent assistant on an electronic device, waking up the intelligent assistant from a sleep mode in response to the activation, and determining an amount of vocabulary the intelligent assistant acts upon during a listening mode based on a type of the activation.

Abstract: A method comprising detecting an activation of an intelligent assistant on an electronic device, waking up the intelligent assistant from a sleep mode in response to the activation, and determining an amount of vocabulary the intelligent assistant acts upon during a listening mode based on a type of the activation.

Abstract: A method comprising detecting an activation of an intelligent assistant on an electronic device, waking up the intelligent assistant from a sleep mode in response to the activation, and determining an amount of vocabulary the intelligent assistant acts upon during a listening mode based on a type of the activation.

Abstract: A method comprising detecting an activation of an intelligent assistant on an electronic device, waking up the intelligent assistant from a sleep mode in response to the activation, and determining an amount of vocabulary the intelligent assistant acts upon during a listening mode based on a type of the activation.

Abstract: Micro-Organosphers, including Patient-Derived Micro-Organospheres (PMOS s), apparatuses and methods of making them, and apparatuses and methods of using them. Also described herein are methods and systems for screening a patient using these Patient-Derived Micro-Organospheres, including personalized therapies.

Abstract: Micro-Organospheres, including Patient-Derived Micro-Organospheres (PMOSs), apparatuses and methods of making them, and apparatuses and methods of using them. Also described herein are methods and systems for screening a patient using these Patient-Derived Micro-Organospheres, including personalized therapies.

Abstract: Micro-Organosphers, including Patient-Derived Micro-Organospheres (PMOSs), apparatuses and methods of making them, and apparatuses and methods of using them. Also described herein are methods and systems for screening a patient using these Patient-Derived Micro-Organospheres, including personalized therapies.

Abstract: A method comprising detecting an activation of an intelligent assistant on an electronic device, waking up the intelligent assistant from a sleep mode in response to the activation, and determining an amount of vocabulary the intelligent assistant acts upon during a listening mode based on a type of the activation.

Abstract: A method comprising detecting an activation of an intelligent assistant on an electronic device, waking up the intelligent assistant from a sleep mode in response to the activation, and determining an amount of vocabulary the intelligent assistant acts upon during a listening mode based on a type of the activation.

Abstract: Patient specific clinical trials and associated methods of treatment are disclosed. According to an aspect, a method includes generating a patient specific tumor model. The method also includes testing one or more drugs on the patient specific tumor model. Further, the method includes treating a patient based on the results of the patient specific tumor model tests.

Abstract: A method comprising detecting an activation of an intelligent assistant on an electronic device, waking up the intelligent assistant from a sleep mode in response to the activation, and determining an amount of vocabulary the intelligent assistant acts upon during a listening mode based on a type of the activation.

Abstract: A method comprising detecting an activation of an intelligent assistant on an electronic device, waking up the intelligent assistant from a sleep mode in response to the activation, and determining an amount of vocabulary the intelligent assistant acts upon during a listening mode based on a type of the activation.

Abstract: Precision drug screening methods and apparatuses for personalized cancer therapies include the formation of a library of mature Micro-Organospheres, including Patient-Derived Micro-Organospheres (PMOSs), from a single patient tissue sample, such as from a tumor sample, are described. Also described herein are methods and systems for screening a patient using these Patient-Derived Micro-Organospheres, including personalized therapies.

Abstract: A modular coco coir grow bag system for cannabis plant includes a starter block comprising a growth medium, wherein the growth medium is adapted to receive a peat based plug with a seedling or cutting of the plant. The system further includes a grow bag comprising a growth medium, wherein the growth medium is adapted to receive at least a portion of the starter block. The growth media of the starter block and the grow bag comprises coconut materials, wherein the starter block and grow bag are provided in a compressed format which expands upon hydration. The grow bag further comprises apertures for water drainage and a mesh insert adapted to hinder exit of coarse particulate matter during water drainage.

Abstract: A web server sends a first coordinator to a first browser of a first mobile device. The first coordinator is a set of instructions executable by the first browser. The web server also sends a second coordinator to a second browser of a second mobile device. The second coordinator is a set of instructions executable by the second browser. The first coordinator, when executed by the first browser, cause the first browser to: send a first request for information to the second browser, over the web server; wait until the requested information is received from the second coordinator over the web server; and when the requested information is received from the second coordinator, perform a first action based on the requested information received from the second coordinator. The first request includes a first token, and the requested information includes a next token.

Abstract: Micro-Organosphers, including Patient-Derived Micro-Organospheres (PMOS s), apparatuses and methods of making them, and apparatuses and methods of using them. Also described herein are methods and systems for screening a patient using these Patient-Derived Micro-Organospheres, including personalized therapies.

Abstract: A method comprising detecting an activation of an intelligent assistant on an electronic device, waking up the intelligent assistant from a sleep mode in response to the activation, and determining an amount of vocabulary the intelligent assistant acts upon during a listening mode based on a type of the activation.

Abstract: A system for facilitating communications in a mesh network is provided. One or more devices of the mesh network may participate as routing nodes to provide range extension for any other devices in the mesh network that would otherwise be out of range from one another. In one or more implementations, Bluetooth Low Energy (BLE) may be used as the physical transport of the mesh network.

Abstract: CRISPR/CAS-related compositions and methods for treatment of DMD, BMD, or DCM type 3B are described.

Abstract: A system for facilitating communications in a mesh network is provided. One or more devices of the mesh network may participate as routing nodes to provide range extension for any other devices in the mesh network that would otherwise be out of range from one another. In one or more implementations, Bluetooth Low Energy (BLE) may be used as the physical transport of the mesh network.